October 27, 2018 to October 29, 2018

Session No.59 Immunotherapy and Biotherapy, co-chairs: Zhigang Tian and Eric Vivier, October 29th, 8:30 - 12:00

Oct 29, 9:00 - 9:30:
Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells, Eric Vivier

Visit the World Life Science Conference website